{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T10:40:03Z","timestamp":1734864003761,"version":"3.32.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,22]]},"DOI":"10.7759\/cureus.76174","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T09:45:26Z","timestamp":1734860726000},"source":"Crossref","is-referenced-by-count":0,"title":["Reversible Dilated Cardiomyopathy Associated With Herpes Simplex Virus Infection: A Case Report"],"prefix":"10.7759","author":[{"given":"T\u00e2nia F","family":"Mendes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara F","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno A","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss HP","year":"2019","unstructured":"Schultheiss HP, Fairweather D, Caforio AL, et al.. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019, 5:32. 10.1038\/s41572-019-0084-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott P","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, et al.. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008, 29:270-6. 10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040603","article-title":"Epidemiological impact of myocarditis","volume":"10","author":"Golpour A","year":"2021","unstructured":"Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological impact of myocarditis. J Clin Med. 2021, 10:603. 10.3390\/jcm10040603","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1030440","article-title":"Persistent viral infections and their role in heart disease","volume":"13","author":"Badrinath A","year":"2022","unstructured":"Badrinath A, Bhatta S, Kloc A. Persistent viral infections and their role in heart disease. Front Microbiol. 2022, 13:1030440. 10.3389\/fmicb.2022.1030440","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe C","year":"2021","unstructured":"Tsch\u00f6pe C, Ammirati E, Bozkurt B, et al.. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021, 18:169-93. 10.1038\/s41569-020-00435-x","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.908663","article-title":"Viral myocarditis: classification, diagnosis, and clinical implications","volume":"9","author":"Sozzi FB","year":"2022","unstructured":"Sozzi FB, Gherbesi E, Faggiano A, et al.. Viral myocarditis: classification, diagnosis, and clinical implications. Front Cardiovasc Med. 2022, 9:908663. 10.3389\/fcvm.2022.908663","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14740\/cr1653","article-title":"Efficacy of beta-blockers and angiotensin-converting enzyme inhibitors in non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis","volume":"15","author":"Llerena-Velastegui J","year":"2024","unstructured":"Llerena-Velastegui J, Santamaria-Lasso M, Mejia-Mora M, et al.. Efficacy of beta-blockers and angiotensin-converting enzyme inhibitors in non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis. Cardiol Res. 2024, 15:281-97. 10.14740\/cr1653","journal-title":"Cardiol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral myocarditis - incidence, diagnosis and management","volume":"34","author":"Olejniczak M","year":"2020","unstructured":"Olejniczak M, Schwartz M, Webber E, Shaffer A, Perry TE. Viral myocarditis - incidence, diagnosis and management. J Cardiothorac Vasc Anesth. 2020, 34:1591-601. 10.1053\/j.jvca.2019.12.052","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper LT Jr","year":"2009","unstructured":"Cooper LT Jr. Myocarditis. N Engl J Med. 2009, 360:1526-38. 10.1056\/NEJMra0800028","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225240","article-title":"Viral myocarditis - from pathophysiology to treatment","volume":"10","author":"Schultheiss HP","year":"2021","unstructured":"Schultheiss HP, Baumeier C, Aleshcheva G, Bock CT, Escher F. Viral myocarditis - from pathophysiology to treatment. J Clin Med. 2021, 10:5240. 10.3390\/jcm10225240","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-7839","article-title":"Management of left ventricular thrombus: a narrative review","volume":"9","author":"Cruz Rodriguez JB","year":"2021","unstructured":"Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021, 9:520. 10.21037\/atm-20-7839","journal-title":"Ann Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2023-323484","article-title":"Efficacy and safety of colchicine for the treatment of myopericarditis","volume":"110","author":"Collini V","year":"2024","unstructured":"Collini V, De Martino M, Andreis A, et al.. Efficacy and safety of colchicine for the treatment of myopericarditis. Heart. 2024, 110:735-9. 10.1136\/heartjnl-2023-323484","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9357-4","article-title":"Viral myocarditis: from experimental models to molecular diagnosis in patients","volume":"18","author":"Pankuweit S","year":"2013","unstructured":"Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013, 18:683-702. 10.1007\/s10741-012-9357-4","journal-title":"Heart Fail Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3371","article-title":"Diagnosis and treatment of acute myocarditis: a review","volume":"329","author":"Ammirati E","year":"2023","unstructured":"Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA. 2023, 329:1098-113. 10.1001\/jama.2023.3371","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102710","article-title":"Efficacy of immunosuppressive therapy in myocarditis: a 30-year systematic review and meta analysis","volume":"20","author":"Cheng CY","year":"2021","unstructured":"Cheng CY, Cheng GY, Shan ZG, et al.. Efficacy of immunosuppressive therapy in myocarditis: a 30-year systematic review and meta analysis. Autoimmun Rev. 2021, 20:102710. 10.1016\/j.autrev.2020.102710","journal-title":"Autoimmun Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071565","article-title":"Immunomodulating and immunosuppressive therapy for virus-negative immune-mediated myocarditis","volume":"12","author":"Frustaci A","year":"2024","unstructured":"Frustaci A, Letizia C, Alfarano M, Marchionni G, Verardo R, Chimenti C. Immunomodulating and immunosuppressive therapy for virus-negative immune-mediated myocarditis. Biomedicines. 2024, 12:1565. 10.3390\/biomedicines12071565","journal-title":"Biomedicines"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac348","article-title":"Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial","volume":"43","author":"Chimenti C","year":"2022","unstructured":"Chimenti C, Russo MA, Frustaci A. Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial. Eur Heart J. 2022, 43:3463-73. 10.1093\/eurheartj\/ehac348","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis - diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack A","year":"2015","unstructured":"Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis - diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015, 12:670-80. 10.1038\/nrcardio.2015.108","journal-title":"Nat Rev Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13808","article-title":"Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy","volume":"9","author":"Deng Y","year":"2022","unstructured":"Deng Y, Zhang N, Hua W, et al.. Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy. ESC Heart Fail. 2022, 9:1269-78. 10.1002\/ehf2.13808","journal-title":"ESC Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010705","article-title":"Dilated cardiomyopathy with mid-range ejection fraction at diagnosis: characterization and natural history","volume":"8","author":"Gentile P","year":"2019","unstructured":"Gentile P, Merlo M, Cannat\u00e0 A, et al.. Dilated cardiomyopathy with mid-range ejection fraction at diagnosis: characterization and natural history. J Am Heart Assoc. 2019, 8:e010705. 10.1161\/JAHA.118.010705","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study","volume":"58","author":"McNamara DM","year":"2011","unstructured":"McNamara DM, Starling RC, Cooper LT, et al.. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol. 2011, 58:1112-18. 10.1016\/j.jacc.2011.05.033","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0121","article-title":"Acute myocarditis: aetiology, diagnosis and management","volume":"21","author":"Lampejo T","year":"2021","unstructured":"Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Lond). 2021, 21:e505-10. 10.7861\/clinmed.2021-0121","journal-title":"Clin Med (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead132","article-title":"Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias","volume":"3","author":"Peretto G","year":"2023","unstructured":"Peretto G, Sala S, Carturan E, et al.. Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias. Eur Heart J Open. 2023, 3:oead132. 10.1093\/ehjopen\/oead132","journal-title":"Eur Heart J Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suz212","article-title":"Heart failure in dilated non-ischaemic cardiomyopathy","volume":"21","author":"Seferovi\u0107 PM","year":"2019","unstructured":"Seferovi\u0107 PM, Polovina MM, Coats AJ. Heart failure in dilated non-ischaemic cardiomyopathy. Eur Heart J Suppl. 2019, 21:M40-3. 10.1093\/eurheartj\/suz212","journal-title":"Eur Heart J Suppl"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday BP","year":"2019","unstructured":"Halliday BP, Wassall R, Lota AS, et al.. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019, 393:61-73. 10.1016\/S0140-6736(18)32484-X","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289653-reversible-dilated-cardiomyopathy-associated-with-herpes-simplex-virus-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T09:45:27Z","timestamp":1734860727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289653-reversible-dilated-cardiomyopathy-associated-with-herpes-simplex-virus-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,22]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.76174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,22]]}}}